Mount Yale Investment Advisors, LLC Astrazeneca PLC Transaction History
Mount Yale Investment Advisors, LLC
- $1.2 Billion
- Q4 2024
A detailed history of Mount Yale Investment Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Mount Yale Investment Advisors, LLC holds 44,653 shares of AZN stock, worth $3.4 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
44,653
Previous 47,815
6.61%
Holding current value
$3.4 Million
Previous $3.73 Million
21.48%
% of portfolio
0.24%
Previous 0.36%
Shares
28 transactions
Others Institutions Holding AZN
# of Institutions
1,365Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.6 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.13 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.86 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.82 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.83 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $236B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...